Dec 06 2024 This Week in Cardiology

The MI paradox of risk scores, the CELEBRATE trial of a new subcutaneous glycoprotein IIb/IIIA inhibitor (with its funny endpoint), the SURPASS CVOT trial, and the bad story of andexanet alfa are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is inte ...  Afficher plus

An elegant study in post-TAVI atrioventricular block, a PSA for my structural colleagues, revascularization in women, and a CTO PCI trial are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a part ...  Afficher plus

<div class="OutlineElement Ltr SCXW99262018 BCX0">

<span class= "TextRun SCXW99262018 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class= "NormalTextRun SCXW99262018 BCX0">In this interview,</span> <span class="NormalTextRu ...

Join CardioNerds Heart Failure Section Chair Dr. Jenna Skowronski, episode lead Dr. Merna Hussein, and expert faculty Dr. Milton Packer as they discuss the SUMMIT trial. The SUMMIT trial randomized 731 patients with HFpEF with LVEF ≥ 50% and obesity with BMI ≥ 30 kg/m2 to receive ...  Afficher plus

Join my FREE 3-Day Water Fast Challenge - October 15th. It's the exact protocol I use with pro athletes and Fortune 500 CEOs to flush inflammation and kickstart autophagy. Sign up here! http://bit.ly/4nTILPt Could the answer to your chronic health struggles be hiding in plain sig ...  Afficher plus

Two Atlanta entrepreneurs discovered something more valuable than any business strategy: a daily practice that builds unshakeable mental resilience while creating thriving communities nationwide. Kyle Ponton and Sam Maxwell share how their journey from DIY ice barrels to building ...  Afficher plus